^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    biropepimut-S (GL-0817)

    i
    Other names: GL-0817, MAGE-A3 vaccine
    Associations

    News

    Trials
    Company:
    Gliknik, University of Pennsylvania
    Drug class:
    MAGE-A3 modulator
    Related drugs:
    Associations

    News

    Trials
    over3years
    Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity (clinicaltrials.gov)
    P2, N=80, Completed, Gliknik Inc. | Active, not recruiting --> Completed
    Trial completion
    |
    MAGEA3 (MAGE Family Member A3)
    |
    cyclophosphamide • Hiltonol (poly-ICLC) • Leukine (sargramostim) • biropepimut-S (GL-0817)